MARSHALL WACE, LLP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,137,996

+$1,937,409 QoQ

Shares Held

2,012,458

+115.6% QoQ

Ownership

1.94%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 162 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. LRMR ranks #87 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,137,996	2,012,458	+115.6%	Shares	Other	2026-08-13
2026-03-31	$4,200,587	933,464	+746.3%	Shares	Other	2026-05-15
2024-12-31	$426,875	110,304	+52.2%	Shares	Other	2025-02-13
2024-09-30	$474,835	72,494	-23.9%	Shares	Other	2024-11-14
2024-06-30	$690,301	95,214	-4.6%	Shares	Other	2024-08-14
2024-03-31	$757,390	99,788	+69.4%	Shares	Other	2024-05-15
2023-03-31	$266,853	58,908	+52.2%	Shares	Other	2023-05-15
2022-09-30	$123,872	38,710	+239.8%	Shares	Other	2022-11-14
2021-12-31	$122,919	11,392	-57.2%	Shares	Other	2022-02-14
2021-09-30	$306,548	26,587	+8.5%	Shares	Sole	2021-11-15
2021-06-30	$240,531	24,494	-54.7%	Shares	Sole	2021-08-13
2021-03-31	$790,605	54,114	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.